Atlas FDA

ADVIA® Chemistry Total Bilirubin_2 (TBIL_2)

FDA 510(k) clearance K170065 · decided 2017-03-09

Clearance details

K-number
K170065
Device name
ADVIA® Chemistry Total Bilirubin_2 (TBIL_2)
Applicant
Siemens Healthcare Diagnostics, Inc.
Decision
Substantially Equivalent
Date received
2017-01-09
Decision date
2017-03-09
Days to decision
59 days
Clearance type
Traditional
Product code
JFM
Device class
2
Regulation number
862.1110
Medical specialty
Clinical Chemistry
Advisory committee
Clinical Chemistry
Location
Tarrytown, NY, US
Third-party review
No
Expedited review
No

+ Add to Predicate Builder ◉ Watch Siemens Healthcare Diagnostics

The Builder collects up to 8 candidate devices side by side with yours, then exports the substantial-equivalence comparison scaffold. How it works

Need this as data, not a web page?

Query all 176,000+ clearances through the Atlas FDA API, or subscribe to weekly change alerts. Self-serve from $29/mo.

Similar devices under this product code

Devices cleared under the same product code - the starting set for predicate research.

RecordFirmDate
Direct Bilirubin (K152343)Randox Laboratories Limited2016-02-16
Total Bilirubin (K152344)Randox Laboratories Limited2016-01-28
ADVIA CHEMISTRY TOTAL BILIRUBIN_2 (K063845)Bayer Healthcare, LLC2007-12-07
WAKO DIRECT BILIRUBIN V, MODELS 996-23591, 412-22901, 992-23691, 998-23791 (K053132)Wako Chemicals USA, Inc.2005-12-30
WAKO TOTAL BILIRUBIN V, MODELS 410-22701, 998-23291, 416-22801, 990-23191 (K053131)Wako Chemicals USA, Inc.2005-12-30
DRI-STAT ENZYMATIC BILIRUBIN REAGENT, SYNCHRON SYSTEMS BILIRUBIN CALIBRATOR (K053090)Beckman Coulter, Inc.2005-12-16
DIRECT BILIRUBIN LIQUICOLOR AND TOTAL BILIRUBIN LIQUICOLOR (K050266)Stanbio Laboratory2005-06-30
WAKO TOTAL BILIRUBIN V (K970985)Wako Chemicals USA, Inc.1997-04-21
ENZYMATIC BILIRUBIN (TOTAL), CATALOGUE NO. 202-14 (K904660)Diagnostic Chemicals, Ltd. (Usa)1990-11-20
DRI-STAT ENZYMATIC BILIRUBIN TEST KIT (K843174)Beckman Instruments, Inc.1984-09-14

Recalls involving this device

RecordFirmDate
Atellica CH Total Bilirubin_2 -In vitro diagnostic use in the quantitative determination o recall (Z-2471-2023)Siemens Healthcare Diagnostics, Inc.2023-08-28

PMA approvals by this applicant

RecordFirmDate
IMMULITE 2000 PSA (P930027/S039)Siemens Healthcare Diagnostics, Inc.2026-07-27
IMMULITE 2000 AFP (P010007/S026)Siemens Healthcare Diagnostics, Inc.2026-07-27
Atellica IM free PSA II (fPSAII) (P250026)Siemens Healthcare Diagnostics, Inc.2026-05-11
ADVIA Centaur AFP and Atellica IM Alpha Fetoprotein (AFP) (P930036/S026)Siemens Healthcare Diagnostics, Inc.2026-05-11
IMMULITE 2000 AFP (P010007/S025)Siemens Healthcare Diagnostics, Inc.2026-04-21
IMMULITE 2000 PSA (P930027/S038)Siemens Healthcare Diagnostics, Inc.2026-04-21
Atellica IM Total PSA II (tPSAII) (P240021)Siemens Healthcare Diagnostics, Inc.2025-12-03
IMMULITE 2000 PSA (P930027/S037)Siemens Healthcare Diagnostics, Inc.2025-10-30